Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain.
Researchers have conducted a population-based case–control study of major coronary events ( i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease ) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls.
Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart.
The overall average of the mean doses to the whole heart was 4.9 Gy ( range, 0.03 to 27.72 ).
Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray ( P less than 0.001 ), with no apparent threshold.
The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy.
The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy.
In conclusion, exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease.
The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years.
Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. ( Xagena )
Darby SC et al, N Engl J Med 2013; 368:987-998